The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival benefits of adjuvant chemotherapy in high-grade stage II and III colon cancer.
Walter Tsang
No relevant relationships to disclose
Argyrios Ziogas
No relevant relationships to disclose
Chaitali Singh Nangia
No relevant relationships to disclose
Jason A. Zell
No relevant relationships to disclose